Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Susan Blum is recorded as CFO at CorMedix Inc. (CRMD). CorMedix Inc. reported in an 8-K filed September 2, 2025 that Susan Blum was appointed Executive Vice President and Chief Financial Officer. CorMedix Inc. reported in an 8-K filed September 2, 2025 that Susan Blum was appointed Chief Financial Officer, effective August 29, 2025. Susan Blum has spoken on 4 earnings calls across 1 company, most recently for CorMedix Inc. on August 13, 2026.
“Effective upon the Closing Date (as defined in that certain Agreement and Plan of Merger, by and among the Company, Melinta Therapeutics, LLC, and the other parties thereto, dated as of August 7, 2025) (the "Merger Agreement" and such Closing Date, the "Effective Date" hereunder), Executive will serve as the Company's Executive Vice President and Chief Financial Officer.”
“The Company announced today that Susan Blum, Elizabeth Hurlburt and Matthew David (each, an “Executive”) have been appointed to serve as the Company’s Chief Financial Officer, Chief Operating Officer and Chief Business Officer, respectively, each effective as of the Closing Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
CRMD
CFO
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
